Covadonga Paneda, PhD

Chief Development Officer at Altamira Therapeutics

Speaker

Covadonga Pañeda, Ph.D. has over 15 years of experience in leadership and management of biotechnology companies. Before joining Altamira in April 2022, she spent seven years managing Sylentis’ R&D efforts, a clinical stage RNAi company, two years leading the translational activities of start-up companies Isquaemia Biotech and Mirnax Biosens; and most recently, she served as Director of Development at LiMM Therapeutics, a French neuroimmune biopharmaceutical company.

Dr. Pañeda holds a Ph.D. in Biochemistry and Molecular Biology from the Faculty of Medicine at Universidad Autónoma, Madrid, Spain; she spent four years as a postdoc at Scripps Research Institute in La Jolla, California, USA, and holds a Master in Management of Biotechnology Companies awarded by Fundación Genoma España, Madrid, Spain.